Financial Empowerment and Protection Act

House Bill

H.R. 4096

119th Congress

Financial Empowerment and Protection Act

In Committee

Introduced:Jun 24, 2025

Primary Sponsor

Earl L. Carter

Representative

Republican

GA-1

Cosponsors

2

Quick Stats

Policy Area

Health

Summary

This bill would require state Medicaid programs to monitor the use of antipsychotic medications by adults, especially those over 65, those receiving home and community-based services, and those in institutional care settings like nursing homes. Currently, states are only required to monitor the use of these medications for children.

Latest Action

Referred to the Subcommittee on Health.

SponsorEarl L. Carter (R-GA)

Introduced6/24/2025

StatusReferred to the Committee on Financial Services, and in addition to the Committees on Energy and Com

ChamberHouse

Data from Congress.gov

See this page through your district lens

Enter ZIP to personalize representatives and vote context.

Stay on top of this issue

Subscribe for weekly bill and representative updates.

Vote Prediction

Financial Empowerment and Protection Act

This bill would require state Medicaid programs to monitor the use of antipsychotic medications by adults, especially those over 65, those receiving home and community-based services, and those in institutional care settings like nursing homes. Currently, stat

Community Breakdown

Pass

0%

Fail

0%

0 predictions

This bill would require state Medicaid programs to monitor the use of antipsychotic medications by adults, especially those over 65, those receiving home and community-based services, and those in institutional care settings like nursing homes. Currently, states are only required to monitor the use of these medications for children.

Bill Number: 4096
Sponsor: Earl L. Carter (R-GA)
Introduced: 6/24/2025
Status: Referred to the Committee on Financial Services, and in addition to the Committees on Energy and Com
Policy Area: Health

Data from Congress.gov

AI-generated summary

Fact Sheet

Title: Financial Empowerment and Protection Act
Bill Number: 4096
Sponsor: Earl L. Carter (R-GA)
Status: Referred to the Committee on Financial Services, and in addition to the Committees on Energy and Com
Introduced: 6/24/2025
Summary: This bill would require state Medicaid programs to monitor the use of antipsychotic medications by adults, especially those over 65, those receiving home and community-based services, and those in institutional care settings like nursing homes. Currently, states are only required to monitor the use

Data from Congress.gov

AI Summary

Plain-English explanation of this bill

This bill would require state Medicaid programs to monitor the use of antipsychotic medications by adults, especially those over 65, those receiving home and community-based services, and those in institutional care settings like nursing homes. Currently, states are only required to monitor the use of these medications for children.

Last updated: 12/30/2025

Official Summary

Congressional Research Service summary

<p>This bill requires state Medicaid programs to monitor (through their drug utilization review programs) the use of antipsychotic medications by adults, particularly individuals over the age of 65, individuals who receive home- and community-based services, and individuals who are in institutional care settings (e.g., nursing facilities). (States are currently only required to monitor the use of antipsychotic medications by children.) </p>

Key Points

Main provisions of the bill

Expands state Medicaid program requirements to monitor antipsychotic medication use by adults, not just children
Focuses monitoring on adults over 65, those receiving home/community-based services, and those in institutional care settings
Aims to ensure appropriate and responsible use of antipsychotic medications for vulnerable adult populations

How This Impacts Americans

Potential effects on citizens and communities

If passed, this bill would impact Medicaid recipients, especially older adults and those in long-term care facilities, by requiring closer monitoring of antipsychotic medication use. This could lead to more oversight and potentially reduce inappropriate prescribing of these powerful drugs for vulnerable populations.

Policy Areas

Primary Policy Area

Health

Related Subjects

Health information and medical records

Medicaid

Mental health

Prescription drugs

State and local government operations

Scope & Jurisdiction

Jurisdiction Level

federal

Congressional Session

119th Congress

Citation Reference

4096, 119th Congress (2025). "Financial Empowerment and Protection Act". Source: Voter's Right Platform. https://votersright.org/bills/118-hr-4096

Public Opinions

Community submissions related to this bill.

Share your opinion

No public opinions yet. Be the first to submit one for this bill.

Related Bills in Health

HR 3021

Empowering Patient Choice of Medical Care Act

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means

HR 2111

To amend the Federal Food, Drug, and Cosmetic Act to exempt the premium cigar industry from certain regulations.

Referred to the House Committee on Energy and Commerce.

HR 2884

Anti-Racism in Public Health Act of 2025

Referred to the House Committee on Energy and Commerce.

S 1406

SOAR Act of 2025

Read twice and referred to the Committee on Finance.